Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bougnères P[au]:

Search results

Items: 1 to 50 of 222

1.

Laparoscopic Sleeve Gastrectomy for Adolescents Under 18 Years Old with Severe Obesity.

Lainas P, De Filippo G, Di Giuro G, Mikhael R, Bougneres P, Dagher I.

Obes Surg. 2019 Sep 13. doi: 10.1007/s11695-019-04150-6. [Epub ahead of print]

PMID:
31520302
2.

Dynamic demethylation of the IL2RA promoter during in vitro CD4+ T cell activation in association with IL2RA expression.

Belot MP, Castell AL, Le Fur S, Bougnères P.

Epigenetics. 2018;13(5):459-472. doi: 10.1080/15592294.2018.1469893. Epub 2018 Aug 10.

3.

Correction to: Fetal growth is associated with CpG methylation in the P2 promoter of the IGF1 gene.

Le Stunff C, Castell AL, Todd N, Mille C, Belot MP, Frament N, Brailly-Tabard S, Benachi A, Fradin D, Bougnères P.

Clin Epigenetics. 2018 Jun 4;10:74. doi: 10.1186/s13148-018-0506-z. eCollection 2018.

4.

Fetal growth is associated with CpG methylation in the P2 promoter of the IGF1 gene.

Le Stunff C, Castell AL, Todd N, Mille C, Belot MP, Frament N, Brailly-Tabard S, Benachi A, Fradin D, Bougnères P.

Clin Epigenetics. 2018 Apr 19;10:57. doi: 10.1186/s13148-018-0489-9. eCollection 2018. Erratum in: Clin Epigenetics. 2018 Jun 4;10:74.

5.

Impact of social inequalities at birth on the longevity of children born 1914-1916: A cohort study.

Todd N, Le Fur S, Bougnères P, Valleron AJ.

PLoS One. 2017 Oct 16;12(10):e0185848. doi: 10.1371/journal.pone.0185848. eCollection 2017.

6.

The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature.

Ben-Avraham D, Govindaraju DR, Budagov T, Fradin D, Durda P, Liu B, Ott S, Gutman D, Sharvit L, Kaplan R, Bougnères P, Reiner A, Shuldiner AR, Cohen P, Barzilai N, Atzmon G.

Sci Adv. 2017 Jun 16;3(6):e1602025. doi: 10.1126/sciadv.1602025. eCollection 2017 Jun.

7.

Genome-Wide Methylation Analysis Identifies Specific Epigenetic Marks In Severely Obese Children.

Fradin D, Boëlle PY, Belot MP, Lachaux F, Tost J, Besse C, Deleuze JF, De Filippo G, Bougnères P.

Sci Rep. 2017 Apr 7;7:46311. doi: 10.1038/srep46311.

8.

Prenatal loss of father during World War One is predictive of a reduced lifespan in adulthood.

Todd N, Valleron AJ, Bougnères P.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4201-4206. doi: 10.1073/pnas.1617911114. Epub 2017 Apr 4.

9.

Erratum to: A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.

Rothenbuhler A, Linglart A, Bougnères P.

Int J Pediatr Endocrinol. 2017;2017:4. doi: 10.1186/s13633-017-0043-0. Epub 2017 Feb 27.

10.

An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21-/- mouse model.

Perdomini M, Dos Santos C, Goumeaux C, Blouin V, Bougnères P.

Gene Ther. 2017 May;24(5):275-281. doi: 10.1038/gt.2017.10. Epub 2017 Feb 6.

PMID:
28165447
11.

Using spatio-temporal surveillance data to test the infectious environment of children before type 1 diabetes diagnosis.

Bougnères P, Le Fur S; Isis-Diab collaborative group, Valtat S, Kamatani Y, Lathrop M, Valleron AJ.

PLoS One. 2017 Feb 2;12(2):e0170658. doi: 10.1371/journal.pone.0170658. eCollection 2017.

12.

Deferring surgical treatment of ambiguous genitalia into adolescence in girls with 21-hydroxylase deficiency: a feasibility study.

Bougnères P, Bouvattier C, Cartigny M, Michala L.

Int J Pediatr Endocrinol. 2017;2017:3. doi: 10.1186/s13633-016-0040-8. Epub 2017 Jan 28.

13.

Knock-In of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-Dependent Protein Kinase A Activation: A Model of Type 1 Acrodysostosis.

Le Stunff C, Tilotta F, Sadoine J, Le Denmat D, Briet C, Motte E, Clauser E, Bougnères P, Chaussain C, Silve C.

J Bone Miner Res. 2017 Feb;32(2):333-346. doi: 10.1002/jbmr.2987. Epub 2016 Oct 24.

14.

Association of environmental markers with childhood type 1 diabetes mellitus revealed by a long questionnaire on early life exposures and lifestyle in a case-control study.

Balazard F, Le Fur S, Valtat S, Valleron AJ, Bougnères P; Isis-Diab collaborative group, Thevenieau D, Chatel CF, Desailloud R, Bony-Trifunovic H, Ducluzeau PH, Coutant R, Caudrelier S, Pambou A, Dubosclard E, Joubert F, Jan P, Marcoux E, Bertrand AM, Mignot B, Penformis A, Stuckens C, Piquemal R, Barat P, Rigalleau V, Stheneur C, Fournier S, Kerlan V, Metz C, Fargeot-Espaliat A, Reznic Y, Olivier F, Gueorguieva I, Monier A, Radet C, Gajdos V, Terral D, Vervel C, Bendifallah D, Signor CB, Dervaux D, Benmahammed A, Loeuille GA, Popelard F, Guillou A, Benhamou PY, Khoury J, Brossier JP, Bassil J, Clavel S, Le Luyer B, Bougnères P, Labay F, Guemas I, Weill J, Cappoen JP, Nadalon S, Lienhardt-Roussie A, Paoli A, Kerouedan C, Yollin E, Nicolino M, Simonin G, Cohen J, Atlan C, Tamboura A, Dubourg H, Pignol ML, Talon P, Jellimann S, Chaillous L, Baron S, Bortoluzzi MN, Baechler E, Salet R, Zelinsky-Gurung A, Dallavale F, Larger E, Laloi-Michelin M, Gautier JF, Guérin B, Oilleau L, Pantalone L, Lukas C, Guilhem I, De Kerdanet M, Wielickzo MC, Priou-Guesdon M, Richard O, Kurtz F, Laisney N, Ancelle D, Parlier G, Boniface C, Bockel DP, Dufillot D, Razafimahefa B, Gourdy P, Lecomte P, Pepin-Donat M, Combes-Moukhovsky ME, Zymmermann B, Raoulx M, Dumont AG.

BMC Public Health. 2016 Sep 29;16(1):1021.

15.

Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion.

Lambert AS, Bougneres P.

Int J Pediatr Endocrinol. 2016;2016:13. doi: 10.1186/s13633-016-0031-9. Epub 2016 Jul 4.

16.

Role of DNA methylation at the placental RTL1 gene locus in type 1 diabetes.

Belot MP, Nadéri K, Mille C, Boëlle PY, Benachi A, Bougnères P, Fradin D.

Pediatr Diabetes. 2017 May;18(3):178-187. doi: 10.1111/pedi.12387. Epub 2016 May 13.

PMID:
27174469
17.

Higher methylation of the IGF1 P2 promoter is associated with idiopathic short stature.

Ouni M, Castell AL, Rothenbuhler A, Linglart A, Bougnères P.

Clin Endocrinol (Oxf). 2016 Feb;84(2):216-221. doi: 10.1111/cen.12867. Epub 2015 Sep 3.

PMID:
26218795
18.

Primordial Influence of Post-operative Compliance on Weight Loss After Adolescent Laparoscopic Adjustable Gastric Banding.

Khen-Dunlop N, Dabbas M, De Filippo G, Jais JP, Hervieux E, Télion C, Chevallier JM, Michel JL, Aigrain Y, Bougnères P, Goulet O, Révillon Y.

Obes Surg. 2016 Jan;26(1):98-104. doi: 10.1007/s11695-015-1725-4.

PMID:
26058753
19.

[A surgical approach of severe obesity in adolescents].

De Filippo G, Pourcher G, Bougnères P.

Arch Pediatr. 2015 Jul;22(7):682-4. doi: 10.1016/j.arcped.2015.03.010. Epub 2015 Jun 3. French. No abstract available.

PMID:
26047744
20.

A randomized pilot trial of growth hormone with anastrozole versus growth hormone alone, starting at the very end of puberty in adolescents with idiopathic short stature.

Rothenbuhler A, Linglart A, Bougnères P.

Int J Pediatr Endocrinol. 2015;2015(1):4. doi: 10.1186/1687-9856-2015-4. Epub 2015 Feb 16. Erratum in: Int J Pediatr Endocrinol. 2017;2017:4.

21.

The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness.

Ouni M, Belot MP, Castell AL, Fradin D, Bougnères P.

Pharmacogenomics J. 2016 Feb;16(1):102-6. doi: 10.1038/tpj.2015.26. Epub 2015 Apr 14.

22.

Global epidemiology of type 1 diabetes in young adults and adults: a systematic review.

Diaz-Valencia PA, Bougnères P, Valleron AJ.

BMC Public Health. 2015 Mar 17;15:255. doi: 10.1186/s12889-015-1591-y. Review.

23.

Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test.

Ouni M, Castell AL, Linglart A, Bougnères P.

J Clin Endocrinol Metab. 2015 Jun;100(6):E919-25. doi: 10.1210/jc.2015-1413. Epub 2015 Apr 2.

24.

The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.

Ouni M, Gunes Y, Belot MP, Castell AL, Fradin D, Bougnères P.

Clin Epigenetics. 2015 Mar 13;7:22. doi: 10.1186/s13148-015-0062-8. eCollection 2015.

25.

Growth hormone treatment for childhood short stature and risk of stroke in early adulthood.

Linglart A, Tauber M, Bougneres P, Lebouc Y, Chatelain P.

Neurology. 2015 Mar 10;84(10):1062-3. doi: 10.1212/WNL.0000000000001385. No abstract available.

PMID:
25754806
26.

Covariation of the incidence of type 1 diabetes with country characteristics available in public databases.

Diaz-Valencia PA, Bougnères P, Valleron AJ.

PLoS One. 2015 Feb 23;10(2):e0118298. doi: 10.1371/journal.pone.0118298. eCollection 2015.

27.

A pilot study of growth hormone administration in boys with predicted adult short stature and near-ending growth.

Rothenbuhler A, Ormières B, Kalifa G, Bougnères P.

Growth Horm IGF Res. 2015 Apr;25(2):96-102. doi: 10.1016/j.ghir.2015.01.002. Epub 2015 Jan 26.

PMID:
25641639
28.

Comparison of a French pediatric type 1 diabetes cohort's responders and non-responders to an environmental questionnaire.

Le Fur S; Isis-Diab collaborative group, Bougnères P, Valleron AJ.

BMC Public Health. 2014 Dec 3;14:1241. doi: 10.1186/1471-2458-14-1241.

29.

Short-term results of single-port sleeve gastrectomy in adolescents with severe obesity.

Pourcher G, De Filippo G, Ferretti S, Piquard C, Dagher I, Bougnères P.

Surg Obes Relat Dis. 2015 Jan-Feb;11(1):65-9. doi: 10.1016/j.soard.2014.05.029. Epub 2014 Jun 3.

PMID:
25393047
30.

Hypomethylation of the promoter of the catalytic subunit of protein phosphatase 2A in response to hyperglycemia.

Tros F, Meirhaeghe A, Hadjadj S, Amouyel P, Bougnères P, Fradin D.

Physiol Rep. 2014 Jul 16;2(7). pii: e12076. doi: 10.14814/phy2.12076.

31.

β cells keep bad epigenetic memories of palmitate.

Fradin D, Bougnères P.

BMC Med. 2014 Jun 23;12:104. doi: 10.1186/1741-7015-12-104.

32.

Decrease in clinical hypoglycemia in young children with type 1 diabetes treated with free-mixed aspart and detemir insulin: an open labeled randomized trial.

Petit-Bibal C, Rothenbuhler A, Lucchini P, Aboumrad B, Castell AL, Le Fur S, Bougnères P.

Pediatr Diabetes. 2015 Aug;16(5):345-53. doi: 10.1111/pedi.12156. Epub 2014 May 29. Erratum in: Pediatr Diabetes. 2016 Mar;17(2):164. Pediatr Diabetes. 2017 Mar;18(2):163.

PMID:
24888575
33.

CpG methylation changes within the IL2RA promoter in type 1 diabetes of childhood onset.

Belot MP, Fradin D, Mai N, Le Fur S, Zélénika D, Kerr-Conte J, Pattou F, Lucas B, Bougnères P.

PLoS One. 2013 Jul 12;8(7):e68093. doi: 10.1371/journal.pone.0068093. Print 2013.

34.

PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance.

Linglart A, Fryssira H, Hiort O, Holterhus PM, Perez de Nanclares G, Argente J, Heinrichs C, Kuechler A, Mantovani G, Leheup B, Wicart P, Chassot V, Schmidt D, Rubio-Cabezas Ó, Richter-Unruh A, Berrade S, Pereda A, Boros E, Muñoz-Calvo MT, Castori M, Gunes Y, Bertrand G, Bougnères P, Clauser E, Silve C.

J Clin Endocrinol Metab. 2012 Dec;97(12):E2328-38. doi: 10.1210/jc.2012-2326. Epub 2012 Oct 5.

PMID:
23043190
35.

XPG and XPF endonucleases trigger chromatin looping and DNA demethylation for accurate expression of activated genes.

Le May N, Fradin D, Iltis I, Bougnères P, Egly JM.

Mol Cell. 2012 Aug 24;47(4):622-32. doi: 10.1016/j.molcel.2012.05.050. Epub 2012 Jul 5.

36.

Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes.

Fradin D, Le Fur S, Mille C, Naoui N, Groves C, Zelenika D, McCarthy MI, Lathrop M, Bougnères P.

PLoS One. 2012;7(5):e36278. doi: 10.1371/journal.pone.0036278. Epub 2012 May 2.

37.

Growth hormone receptor polymorphism and growth hormone therapy response in children: a Bayesian meta-analysis.

Renehan AG, Solomon M, Zwahlen M, Morjaria R, Whatmore A, Audí L, Binder G, Blum W, Bougnères P, Santos CD, Carrascosa A, Hokken-Koelega A, Jorge A, Mullis PE, Tauber M, Patel L, Clayton PE.

Am J Epidemiol. 2012 May 1;175(9):867-77. doi: 10.1093/aje/kwr408. Epub 2012 Apr 10. Review.

PMID:
22494952
38.

Lentiviral hematopoietic cell gene therapy for X-linked adrenoleukodystrophy.

Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Bougnères P, Schmidt M, Kalle CV, Fischer A, Cavazzana-Calvo M, Aubourg P.

Methods Enzymol. 2012;507:187-98. doi: 10.1016/B978-0-12-386509-0.00010-7.

PMID:
22365775
39.

Pineal cysts in children.

Lacroix-Boudhrioua V, Linglart A, Ancel PY, Falip C, Bougnères PF, Adamsbaum C.

Insights Imaging. 2011 Dec;2(6):671-678. Epub 2011 Aug 10.

40.

A pilot study of discontinuous, insulin-like growth factor 1-dosing growth hormone treatment in young children with FGFR3 N540K-mutated hypochondroplasia.

Rothenbuhler A, Linglart A, Piquard C, Bougnères P.

J Pediatr. 2012 May;160(5):849-53. doi: 10.1016/j.jpeds.2011.10.023. Epub 2011 Dec 2.

PMID:
22137367
41.

T2DM: Why Epigenetics?

Fradin D, Bougnères P.

J Nutr Metab. 2011;2011:647514. doi: 10.1155/2011/647514. Epub 2011 Nov 3.

42.

Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism.

Linglart A, Rothenbuhler A, Gueorgieva I, Lucchini P, Silve C, Bougnères P.

J Clin Endocrinol Metab. 2011 Nov;96(11):3308-12. doi: 10.1210/jc.2011-1359. Epub 2011 Aug 24.

PMID:
21865375
43.

Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.

Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, Cancel M, Motte E, Pinto G, Chanson P, Bougnères P, Clauser E, Silve C.

N Engl J Med. 2011 Jun 9;364(23):2218-26. doi: 10.1056/NEJMoa1012717.

44.

[Gene therapy of x-linked adrenoleukodystrophy using hematopoietic stem cells and a lentiviral vector].

Cartier N, Hacein-Bey-Abina S, Von Kalle C, Bougnères P, Fischer A, Cavazzana-Calvo M, Aubourg P.

Bull Acad Natl Med. 2010 Feb;194(2):255-64; discussion 264-8. French.

PMID:
21166117
45.

Risk of corrected QT interval prolongation after pamidronate infusion in children.

Rothenbuhler A, Marchand I, Bougnères P, Linglart A.

J Clin Endocrinol Metab. 2010 Aug;95(8):3768-70. doi: 10.1210/jc.2009-2814. Epub 2010 May 25.

PMID:
20501688
46.

Near normalization of adult height and body proportions by growth hormone in pycnodysostosis.

Rothenbühler A, Piquard C, Gueorguieva I, Lahlou N, Linglart A, Bougnères P.

J Clin Endocrinol Metab. 2010 Jun;95(6):2827-31. doi: 10.1210/jc.2009-2531. Epub 2010 Mar 31.

PMID:
20357177
47.

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.

Puel A, Döffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachée-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougnères PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova JL.

J Exp Med. 2010 Feb 15;207(2):291-7. doi: 10.1084/jem.20091983. Epub 2010 Feb 1.

48.

The exon-3 deletion of the growth hormone receptor (GHR) gene still has a limited impact in clinical endocrinology.

Bougnères P.

J Clin Endocrinol Metab. 2010 Jan;95(1):56-9. doi: 10.1210/jc.2009-2233. No abstract available.

PMID:
20056809
49.

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.

Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, Vidaud M, Abel U, Dal-Cortivo L, Caccavelli L, Mahlaoui N, Kiermer V, Mittelstaedt D, Bellesme C, Lahlou N, Lefrère F, Blanche S, Audit M, Payen E, Leboulch P, l'Homme B, Bougnères P, Von Kalle C, Fischer A, Cavazzana-Calvo M, Aubourg P.

Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242.

50.

Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease.

Hudry E, Van Dam D, Kulik W, De Deyn PP, Stet FS, Ahouansou O, Benraiss A, Delacourte A, Bougnères P, Aubourg P, Cartier N.

Mol Ther. 2010 Jan;18(1):44-53. doi: 10.1038/mt.2009.175. Epub 2009 Aug 4.

Supplemental Content

Loading ...
Support Center